title: Dacomitinib: another option for EGFR-mutant lung cancer?
authors.affiliation: Department of Thoracic Surgery, Kinki University Faculty of Medicine, Osaka-Sayama, Japan. Electronic address: mitsudom@surg.med.kindai.ac.jp.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Mitsudomi
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D058990:Molecular Targeted Therapy; D009154:Mutation / Q000235:genetics*; D052999:Quinazolinones / Q000627:therapeutic use*
chemical_list: D052999:Quinazolinones; C525726:dacomitinib; C512478:EGFR protein, human; D066246:ErbB Receptors